nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—SLC22A7—Methotrexate—systemic scleroderma	0.0894	0.144	CbGbCtD
Clarithromycin—CYP1A2—Pentoxifylline—systemic scleroderma	0.082	0.132	CbGbCtD
Clarithromycin—CYP1A2—Leflunomide—systemic scleroderma	0.0782	0.126	CbGbCtD
Clarithromycin—ABCB1—Lisinopril—systemic scleroderma	0.0717	0.116	CbGbCtD
Clarithromycin—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0649	0.105	CbGbCtD
Clarithromycin—ABCB1—Captopril—systemic scleroderma	0.0537	0.0865	CbGbCtD
Clarithromycin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0422	0.0681	CbGbCtD
Clarithromycin—CYP2C19—Prednisone—systemic scleroderma	0.0419	0.0675	CbGbCtD
Clarithromycin—ABCB1—Prednisone—systemic scleroderma	0.0338	0.0545	CbGbCtD
Clarithromycin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0253	0.0408	CbGbCtD
Clarithromycin—CYP3A4—Prednisone—systemic scleroderma	0.0202	0.0326	CbGbCtD
Clarithromycin—ABCB1—Methotrexate—systemic scleroderma	0.0169	0.0273	CbGbCtD
Clarithromycin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00023	0.000607	CcSEcCtD
Clarithromycin—Fatigue—Mycophenolic acid—systemic scleroderma	0.00023	0.000606	CcSEcCtD
Clarithromycin—Nausea—Mometasone—systemic scleroderma	0.00023	0.000605	CcSEcCtD
Clarithromycin—Anorexia—Lisinopril—systemic scleroderma	0.000229	0.000604	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000229	0.000603	CcSEcCtD
Clarithromycin—Pain—Mycophenolic acid—systemic scleroderma	0.000228	0.000601	CcSEcCtD
Clarithromycin—Constipation—Mycophenolic acid—systemic scleroderma	0.000228	0.000601	CcSEcCtD
Clarithromycin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000601	CcSEcCtD
Clarithromycin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000597	CcSEcCtD
Clarithromycin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000593	CcSEcCtD
Clarithromycin—Dizziness—Captopril—systemic scleroderma	0.000224	0.000591	CcSEcCtD
Clarithromycin—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000224	0.00059	CcSEcCtD
Clarithromycin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000589	CcSEcCtD
Clarithromycin—Depression—Prednisone—systemic scleroderma	0.000223	0.000588	CcSEcCtD
Clarithromycin—Urticaria—Leflunomide—systemic scleroderma	0.000222	0.000585	CcSEcCtD
Clarithromycin—Abdominal pain—Leflunomide—systemic scleroderma	0.000221	0.000583	CcSEcCtD
Clarithromycin—Body temperature increased—Leflunomide—systemic scleroderma	0.000221	0.000583	CcSEcCtD
Clarithromycin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00022	0.000579	CcSEcCtD
Clarithromycin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000579	CcSEcCtD
Clarithromycin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000579	CcSEcCtD
Clarithromycin—Breast disorder—Methotrexate—systemic scleroderma	0.000219	0.000578	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000219	0.000577	CcSEcCtD
Clarithromycin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000577	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000219	0.000576	CcSEcCtD
Clarithromycin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000218	0.000575	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000218	0.000575	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000575	CcSEcCtD
Clarithromycin—Insomnia—Lisinopril—systemic scleroderma	0.000217	0.000573	CcSEcCtD
Clarithromycin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000572	CcSEcCtD
Clarithromycin—Paraesthesia—Lisinopril—systemic scleroderma	0.000216	0.000569	CcSEcCtD
Clarithromycin—Vomiting—Captopril—systemic scleroderma	0.000216	0.000568	CcSEcCtD
Clarithromycin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000566	CcSEcCtD
Clarithromycin—Dyspnoea—Lisinopril—systemic scleroderma	0.000214	0.000564	CcSEcCtD
Clarithromycin—Rash—Captopril—systemic scleroderma	0.000214	0.000564	CcSEcCtD
Clarithromycin—Dermatitis—Captopril—systemic scleroderma	0.000214	0.000563	CcSEcCtD
Clarithromycin—Somnolence—Lisinopril—systemic scleroderma	0.000214	0.000563	CcSEcCtD
Clarithromycin—Headache—Captopril—systemic scleroderma	0.000213	0.00056	CcSEcCtD
Clarithromycin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000559	CcSEcCtD
Clarithromycin—Dyspepsia—Lisinopril—systemic scleroderma	0.000212	0.000557	CcSEcCtD
Clarithromycin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000211	0.000556	CcSEcCtD
Clarithromycin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000211	0.000556	CcSEcCtD
Clarithromycin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000555	CcSEcCtD
Clarithromycin—Asthma—Methotrexate—systemic scleroderma	0.00021	0.000553	CcSEcCtD
Clarithromycin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000551	CcSEcCtD
Clarithromycin—Decreased appetite—Lisinopril—systemic scleroderma	0.000209	0.00055	CcSEcCtD
Clarithromycin—Eosinophilia—Methotrexate—systemic scleroderma	0.000208	0.000547	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000208	0.000547	CcSEcCtD
Clarithromycin—Fatigue—Lisinopril—systemic scleroderma	0.000207	0.000546	CcSEcCtD
Clarithromycin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000544	CcSEcCtD
Clarithromycin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000543	CcSEcCtD
Clarithromycin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000206	0.000543	CcSEcCtD
Clarithromycin—Pancreatitis—Methotrexate—systemic scleroderma	0.000206	0.000542	CcSEcCtD
Clarithromycin—Pain—Lisinopril—systemic scleroderma	0.000206	0.000541	CcSEcCtD
Clarithromycin—Constipation—Lisinopril—systemic scleroderma	0.000206	0.000541	CcSEcCtD
Clarithromycin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000539	CcSEcCtD
Clarithromycin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000536	CcSEcCtD
Clarithromycin—Diarrhoea—Azathioprine—systemic scleroderma	0.000203	0.000534	CcSEcCtD
Clarithromycin—Haemoglobin—Prednisone—systemic scleroderma	0.000202	0.000532	CcSEcCtD
Clarithromycin—Nausea—Captopril—systemic scleroderma	0.000202	0.000531	CcSEcCtD
Clarithromycin—Haemorrhage—Prednisone—systemic scleroderma	0.000201	0.000529	CcSEcCtD
Clarithromycin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000529	CcSEcCtD
Clarithromycin—Asthenia—Leflunomide—systemic scleroderma	0.000201	0.000529	CcSEcCtD
Clarithromycin—Hallucination—Prednisone—systemic scleroderma	0.0002	0.000527	CcSEcCtD
Clarithromycin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000198	0.000522	CcSEcCtD
Clarithromycin—Pruritus—Leflunomide—systemic scleroderma	0.000198	0.000521	CcSEcCtD
Clarithromycin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000197	0.00052	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000197	0.000518	CcSEcCtD
Clarithromycin—Neutropenia—Methotrexate—systemic scleroderma	0.000196	0.000517	CcSEcCtD
Clarithromycin—Dysuria—Methotrexate—systemic scleroderma	0.000196	0.000517	CcSEcCtD
Clarithromycin—Dizziness—Azathioprine—systemic scleroderma	0.000196	0.000516	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000505	CcSEcCtD
Clarithromycin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000192	0.000504	CcSEcCtD
Clarithromycin—Diarrhoea—Leflunomide—systemic scleroderma	0.000191	0.000504	CcSEcCtD
Clarithromycin—Urticaria—Lisinopril—systemic scleroderma	0.000191	0.000503	CcSEcCtD
Clarithromycin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000502	CcSEcCtD
Clarithromycin—Abdominal pain—Lisinopril—systemic scleroderma	0.00019	0.000501	CcSEcCtD
Clarithromycin—Body temperature increased—Lisinopril—systemic scleroderma	0.00019	0.000501	CcSEcCtD
Clarithromycin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000498	CcSEcCtD
Clarithromycin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000189	0.000497	CcSEcCtD
Clarithromycin—Vomiting—Azathioprine—systemic scleroderma	0.000188	0.000496	CcSEcCtD
Clarithromycin—Pneumonia—Methotrexate—systemic scleroderma	0.000188	0.000496	CcSEcCtD
Clarithromycin—Eye disorder—Prednisone—systemic scleroderma	0.000188	0.000495	CcSEcCtD
Clarithromycin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000495	CcSEcCtD
Clarithromycin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000493	CcSEcCtD
Clarithromycin—Infestation—Methotrexate—systemic scleroderma	0.000187	0.000493	CcSEcCtD
Clarithromycin—Infestation NOS—Methotrexate—systemic scleroderma	0.000187	0.000493	CcSEcCtD
Clarithromycin—Rash—Azathioprine—systemic scleroderma	0.000187	0.000492	CcSEcCtD
Clarithromycin—Dermatitis—Azathioprine—systemic scleroderma	0.000187	0.000492	CcSEcCtD
Clarithromycin—Depression—Methotrexate—systemic scleroderma	0.000187	0.000491	CcSEcCtD
Clarithromycin—Flushing—Prednisone—systemic scleroderma	0.000187	0.000491	CcSEcCtD
Clarithromycin—Headache—Azathioprine—systemic scleroderma	0.000186	0.000489	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000185	0.000489	CcSEcCtD
Clarithromycin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000488	CcSEcCtD
Clarithromycin—Dizziness—Leflunomide—systemic scleroderma	0.000185	0.000487	CcSEcCtD
Clarithromycin—Renal failure—Methotrexate—systemic scleroderma	0.000184	0.000484	CcSEcCtD
Clarithromycin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000183	0.000482	CcSEcCtD
Clarithromycin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000183	0.000481	CcSEcCtD
Clarithromycin—Stomatitis—Methotrexate—systemic scleroderma	0.000182	0.00048	CcSEcCtD
Clarithromycin—Angiopathy—Prednisone—systemic scleroderma	0.000182	0.00048	CcSEcCtD
Clarithromycin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000182	0.000479	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000479	CcSEcCtD
Clarithromycin—Immune system disorder—Prednisone—systemic scleroderma	0.000182	0.000478	CcSEcCtD
Clarithromycin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000474	CcSEcCtD
Clarithromycin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000474	CcSEcCtD
Clarithromycin—Haematuria—Methotrexate—systemic scleroderma	0.000178	0.00047	CcSEcCtD
Clarithromycin—Vomiting—Leflunomide—systemic scleroderma	0.000178	0.000469	CcSEcCtD
Clarithromycin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000177	0.000466	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000177	0.000466	CcSEcCtD
Clarithromycin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000177	0.000465	CcSEcCtD
Clarithromycin—Epistaxis—Methotrexate—systemic scleroderma	0.000176	0.000465	CcSEcCtD
Clarithromycin—Rash—Leflunomide—systemic scleroderma	0.000176	0.000465	CcSEcCtD
Clarithromycin—Dermatitis—Leflunomide—systemic scleroderma	0.000176	0.000464	CcSEcCtD
Clarithromycin—Mental disorder—Prednisone—systemic scleroderma	0.000176	0.000464	CcSEcCtD
Clarithromycin—Nausea—Azathioprine—systemic scleroderma	0.000176	0.000463	CcSEcCtD
Clarithromycin—Headache—Leflunomide—systemic scleroderma	0.000175	0.000462	CcSEcCtD
Clarithromycin—Malnutrition—Prednisone—systemic scleroderma	0.000175	0.000461	CcSEcCtD
Clarithromycin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000175	0.00046	CcSEcCtD
Clarithromycin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000457	CcSEcCtD
Clarithromycin—Asthenia—Lisinopril—systemic scleroderma	0.000172	0.000454	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000454	CcSEcCtD
Clarithromycin—Pruritus—Lisinopril—systemic scleroderma	0.00017	0.000448	CcSEcCtD
Clarithromycin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00017	0.000447	CcSEcCtD
Clarithromycin—Haemoglobin—Methotrexate—systemic scleroderma	0.000169	0.000445	CcSEcCtD
Clarithromycin—Rash—Mycophenolic acid—systemic scleroderma	0.000168	0.000443	CcSEcCtD
Clarithromycin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000168	0.000443	CcSEcCtD
Clarithromycin—Haemorrhage—Methotrexate—systemic scleroderma	0.000168	0.000442	CcSEcCtD
Clarithromycin—Hepatitis—Methotrexate—systemic scleroderma	0.000168	0.000442	CcSEcCtD
Clarithromycin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000441	CcSEcCtD
Clarithromycin—Headache—Mycophenolic acid—systemic scleroderma	0.000167	0.00044	CcSEcCtD
Clarithromycin—Pharyngitis—Methotrexate—systemic scleroderma	0.000167	0.000439	CcSEcCtD
Clarithromycin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000439	CcSEcCtD
Clarithromycin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000439	CcSEcCtD
Clarithromycin—Nausea—Leflunomide—systemic scleroderma	0.000166	0.000438	CcSEcCtD
Clarithromycin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000166	0.000437	CcSEcCtD
Clarithromycin—Urethral disorder—Methotrexate—systemic scleroderma	0.000165	0.000434	CcSEcCtD
Clarithromycin—Diarrhoea—Lisinopril—systemic scleroderma	0.000164	0.000433	CcSEcCtD
Clarithromycin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000162	0.000428	CcSEcCtD
Clarithromycin—Visual impairment—Methotrexate—systemic scleroderma	0.000162	0.000426	CcSEcCtD
Clarithromycin—Anaemia—Prednisone—systemic scleroderma	0.000162	0.000426	CcSEcCtD
Clarithromycin—Agitation—Prednisone—systemic scleroderma	0.000161	0.000423	CcSEcCtD
Clarithromycin—Angioedema—Prednisone—systemic scleroderma	0.00016	0.000421	CcSEcCtD
Clarithromycin—Dizziness—Lisinopril—systemic scleroderma	0.000159	0.000419	CcSEcCtD
Clarithromycin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000159	0.000418	CcSEcCtD
Clarithromycin—Nausea—Mycophenolic acid—systemic scleroderma	0.000159	0.000418	CcSEcCtD
Clarithromycin—Malaise—Prednisone—systemic scleroderma	0.000158	0.000416	CcSEcCtD
Clarithromycin—Vertigo—Prednisone—systemic scleroderma	0.000157	0.000414	CcSEcCtD
Clarithromycin—Eye disorder—Methotrexate—systemic scleroderma	0.000157	0.000413	CcSEcCtD
Clarithromycin—Tinnitus—Methotrexate—systemic scleroderma	0.000157	0.000412	CcSEcCtD
Clarithromycin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000156	0.000411	CcSEcCtD
Clarithromycin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000409	CcSEcCtD
Clarithromycin—Loss of consciousness—Prednisone—systemic scleroderma	0.000154	0.000405	CcSEcCtD
Clarithromycin—Vomiting—Lisinopril—systemic scleroderma	0.000153	0.000403	CcSEcCtD
Clarithromycin—Angiopathy—Methotrexate—systemic scleroderma	0.000152	0.000401	CcSEcCtD
Clarithromycin—Immune system disorder—Methotrexate—systemic scleroderma	0.000152	0.0004	CcSEcCtD
Clarithromycin—Rash—Lisinopril—systemic scleroderma	0.000152	0.000399	CcSEcCtD
Clarithromycin—Convulsion—Prednisone—systemic scleroderma	0.000152	0.000399	CcSEcCtD
Clarithromycin—Dermatitis—Lisinopril—systemic scleroderma	0.000151	0.000399	CcSEcCtD
Clarithromycin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000151	0.000399	CcSEcCtD
Clarithromycin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000398	CcSEcCtD
Clarithromycin—Chills—Methotrexate—systemic scleroderma	0.000151	0.000397	CcSEcCtD
Clarithromycin—Headache—Lisinopril—systemic scleroderma	0.000151	0.000397	CcSEcCtD
Clarithromycin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000392	CcSEcCtD
Clarithromycin—Myalgia—Prednisone—systemic scleroderma	0.000149	0.000392	CcSEcCtD
Clarithromycin—Anxiety—Prednisone—systemic scleroderma	0.000148	0.000391	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000148	0.00039	CcSEcCtD
Clarithromycin—Discomfort—Prednisone—systemic scleroderma	0.000147	0.000388	CcSEcCtD
Clarithromycin—Mental disorder—Methotrexate—systemic scleroderma	0.000147	0.000388	CcSEcCtD
Clarithromycin—Malnutrition—Methotrexate—systemic scleroderma	0.000146	0.000385	CcSEcCtD
Clarithromycin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000144	0.00038	CcSEcCtD
Clarithromycin—Dysgeusia—Methotrexate—systemic scleroderma	0.000143	0.000377	CcSEcCtD
Clarithromycin—Nausea—Lisinopril—systemic scleroderma	0.000143	0.000376	CcSEcCtD
Clarithromycin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000143	0.000376	CcSEcCtD
Clarithromycin—Infection—Prednisone—systemic scleroderma	0.000142	0.000374	CcSEcCtD
Clarithromycin—Back pain—Methotrexate—systemic scleroderma	0.000141	0.000372	CcSEcCtD
Clarithromycin—Nervous system disorder—Prednisone—systemic scleroderma	0.00014	0.000369	CcSEcCtD
Clarithromycin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000367	CcSEcCtD
Clarithromycin—Skin disorder—Prednisone—systemic scleroderma	0.000139	0.000365	CcSEcCtD
Clarithromycin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000138	0.000364	CcSEcCtD
Clarithromycin—Anorexia—Prednisone—systemic scleroderma	0.000136	0.000358	CcSEcCtD
Clarithromycin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000136	0.000357	CcSEcCtD
Clarithromycin—Anaemia—Methotrexate—systemic scleroderma	0.000135	0.000356	CcSEcCtD
Clarithromycin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000353	CcSEcCtD
Clarithromycin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00035	CcSEcCtD
Clarithromycin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000349	CcSEcCtD
Clarithromycin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000348	CcSEcCtD
Clarithromycin—Malaise—Methotrexate—systemic scleroderma	0.000132	0.000347	CcSEcCtD
Clarithromycin—Vertigo—Methotrexate—systemic scleroderma	0.000131	0.000346	CcSEcCtD
Clarithromycin—Leukopenia—Methotrexate—systemic scleroderma	0.000131	0.000345	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00013	0.000343	CcSEcCtD
Clarithromycin—Insomnia—Prednisone—systemic scleroderma	0.000129	0.00034	CcSEcCtD
Clarithromycin—Paraesthesia—Prednisone—systemic scleroderma	0.000128	0.000338	CcSEcCtD
Clarithromycin—Cough—Methotrexate—systemic scleroderma	0.000128	0.000336	CcSEcCtD
Clarithromycin—Convulsion—Methotrexate—systemic scleroderma	0.000127	0.000334	CcSEcCtD
Clarithromycin—Dyspepsia—Prednisone—systemic scleroderma	0.000126	0.000331	CcSEcCtD
Clarithromycin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000125	0.00033	CcSEcCtD
Clarithromycin—Chest pain—Methotrexate—systemic scleroderma	0.000124	0.000328	CcSEcCtD
Clarithromycin—Myalgia—Methotrexate—systemic scleroderma	0.000124	0.000328	CcSEcCtD
Clarithromycin—Decreased appetite—Prednisone—systemic scleroderma	0.000124	0.000327	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000124	0.000326	CcSEcCtD
Clarithromycin—Fatigue—Prednisone—systemic scleroderma	0.000123	0.000324	CcSEcCtD
Clarithromycin—Discomfort—Methotrexate—systemic scleroderma	0.000123	0.000324	CcSEcCtD
Clarithromycin—Constipation—Prednisone—systemic scleroderma	0.000122	0.000322	CcSEcCtD
Clarithromycin—Confusional state—Methotrexate—systemic scleroderma	0.00012	0.000317	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000119	0.000314	CcSEcCtD
Clarithromycin—Infection—Methotrexate—systemic scleroderma	0.000119	0.000312	CcSEcCtD
Clarithromycin—Feeling abnormal—Prednisone—systemic scleroderma	0.000118	0.00031	CcSEcCtD
Clarithromycin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000117	0.000308	CcSEcCtD
Clarithromycin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000117	0.000308	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000117	0.000307	CcSEcCtD
Clarithromycin—Skin disorder—Methotrexate—systemic scleroderma	0.000116	0.000305	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000115	0.000304	CcSEcCtD
Clarithromycin—Anorexia—Methotrexate—systemic scleroderma	0.000114	0.0003	CcSEcCtD
Clarithromycin—Urticaria—Prednisone—systemic scleroderma	0.000113	0.000299	CcSEcCtD
Clarithromycin—Body temperature increased—Prednisone—systemic scleroderma	0.000113	0.000297	CcSEcCtD
Clarithromycin—Abdominal pain—Prednisone—systemic scleroderma	0.000113	0.000297	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000109	0.000286	CcSEcCtD
Clarithromycin—Insomnia—Methotrexate—systemic scleroderma	0.000108	0.000284	CcSEcCtD
Clarithromycin—Paraesthesia—Methotrexate—systemic scleroderma	0.000107	0.000282	CcSEcCtD
Clarithromycin—Dyspnoea—Methotrexate—systemic scleroderma	0.000106	0.00028	CcSEcCtD
Clarithromycin—Somnolence—Methotrexate—systemic scleroderma	0.000106	0.000279	CcSEcCtD
Clarithromycin—Hypersensitivity—Prednisone—systemic scleroderma	0.000105	0.000277	CcSEcCtD
Clarithromycin—Dyspepsia—Methotrexate—systemic scleroderma	0.000105	0.000277	CcSEcCtD
Clarithromycin—Decreased appetite—Methotrexate—systemic scleroderma	0.000104	0.000273	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000103	0.000271	CcSEcCtD
Clarithromycin—Fatigue—Methotrexate—systemic scleroderma	0.000103	0.000271	CcSEcCtD
Clarithromycin—Asthenia—Prednisone—systemic scleroderma	0.000102	0.00027	CcSEcCtD
Clarithromycin—Pain—Methotrexate—systemic scleroderma	0.000102	0.000269	CcSEcCtD
Clarithromycin—Pruritus—Prednisone—systemic scleroderma	0.000101	0.000266	CcSEcCtD
Clarithromycin—Feeling abnormal—Methotrexate—systemic scleroderma	9.83e-05	0.000259	CcSEcCtD
Clarithromycin—Diarrhoea—Prednisone—systemic scleroderma	9.77e-05	0.000257	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Methotrexate—systemic scleroderma	9.76e-05	0.000257	CcSEcCtD
Clarithromycin—Urticaria—Methotrexate—systemic scleroderma	9.48e-05	0.00025	CcSEcCtD
Clarithromycin—Dizziness—Prednisone—systemic scleroderma	9.44e-05	0.000249	CcSEcCtD
Clarithromycin—Abdominal pain—Methotrexate—systemic scleroderma	9.43e-05	0.000248	CcSEcCtD
Clarithromycin—Body temperature increased—Methotrexate—systemic scleroderma	9.43e-05	0.000248	CcSEcCtD
Clarithromycin—Vomiting—Prednisone—systemic scleroderma	9.08e-05	0.000239	CcSEcCtD
Clarithromycin—Rash—Prednisone—systemic scleroderma	9e-05	0.000237	CcSEcCtD
Clarithromycin—Dermatitis—Prednisone—systemic scleroderma	8.99e-05	0.000237	CcSEcCtD
Clarithromycin—Headache—Prednisone—systemic scleroderma	8.94e-05	0.000236	CcSEcCtD
Clarithromycin—Hypersensitivity—Methotrexate—systemic scleroderma	8.79e-05	0.000232	CcSEcCtD
Clarithromycin—Asthenia—Methotrexate—systemic scleroderma	8.56e-05	0.000225	CcSEcCtD
Clarithromycin—Nausea—Prednisone—systemic scleroderma	8.48e-05	0.000223	CcSEcCtD
Clarithromycin—Pruritus—Methotrexate—systemic scleroderma	8.44e-05	0.000222	CcSEcCtD
Clarithromycin—Diarrhoea—Methotrexate—systemic scleroderma	8.16e-05	0.000215	CcSEcCtD
Clarithromycin—Dizziness—Methotrexate—systemic scleroderma	7.89e-05	0.000208	CcSEcCtD
Clarithromycin—Vomiting—Methotrexate—systemic scleroderma	7.59e-05	0.0002	CcSEcCtD
Clarithromycin—Rash—Methotrexate—systemic scleroderma	7.52e-05	0.000198	CcSEcCtD
Clarithromycin—Dermatitis—Methotrexate—systemic scleroderma	7.52e-05	0.000198	CcSEcCtD
Clarithromycin—Headache—Methotrexate—systemic scleroderma	7.48e-05	0.000197	CcSEcCtD
Clarithromycin—Nausea—Methotrexate—systemic scleroderma	7.09e-05	0.000187	CcSEcCtD
